Moving Forward

Good morning,

As I approach my 5th year of holding, accumulating and yes, some timely selling of our very compelling cydy stock, I remain convinced we will prevail, but it has to start now. This is it. We must succeed in protocol submission and clean clinical results to subsequent approval. To think a partnership will never happen can only be justified by data unencumbered from butchers like Amarex, KK, and Murray. I'm not saying NP isn't culpable as well, as we are still awaiting the actual evidence presented. For now, that evidence has been convincingly damaging towards the former CRO with many questions and answers, yet to go on record from Murray. GLTA True Longs and Go Leronlimab! Let's gooooo!